Retatrutide 110mg*10vials

$445.00

This is a pharmaceutical-grade, high-purity Retatrutide lyophilized powder, featuring a premium, custom-produced, extra-large 110mg fill. As a cutting-edge triple-target hormone receptor agonist—currently at the forefront of global research into obesity, MASH/NAFLD, and endocrine receptor networks—this 110mg specification is specifically designed for high-throughput industrial-scale screening workstations, multi-year chronic disease cohort studies involving large non-human primate populations, and bulk procurement by multinational pharmaceutical R&D centers or consortia of national key laboratories. This format drastically reduces the cost per gram for research institutions while ensuring flawless data consistency—derived from a single, uniform batch—throughout long-term experimental programs spanning multiple quarters.

Contact the manufacturer via WhatsApp
保证安全结帐
  • 维萨卡
  • 万事达
  • 美国运通卡
  • 发现卡
  • PayPal

描述

Core Features
$\ge 99.0\%$ Ultra-High Purity & 110mg Industrial-Scale Batch Homogeneity: This product is manufactured using industry-leading automated, large-scale Solid-Phase Peptide Synthesis (SPPS) technology. Given Retatrutide’s complex heterogenous peptide chain structure and its substantial 110mg-per-vial dosage, the synthesis control, crude peptide desalting, and advanced conformational purification present significant technical challenges. We employ precise industrial-grade reversed-phase preparative HPLC (RP-HPLC) processes to rigorously eliminate by-products such as racemates, truncated chains, and misaligned sequences. Within this high-capacity 110mg format, every vial guarantees a baseline purity of $\ge 99.0\%$, providing a clean, interference-free matrix for large-scale in vitro receptor affinity assays and long-term in vivo animal metabolic model studies.
Synergistic Triple-Agonist Mechanism: Retatrutide is a standout molecule in metabolic research, capable of binding with high affinity to three key metabolic receptors: GIPR (glucose-dependent insulinotropic polypeptide receptor), GLP-1R (glucagon-like peptide-1 receptor), and GCGR (glucagon receptor). This unique triple-agonist structure makes it an indispensable tool for investigating mechanisms involving multi-receptor synergy—specifically the suppression of appetite, delayed gastric emptying, the browning of white adipose tissue, and the upregulation of overall energy expenditure.
Advanced Cryo-Lyophilization Process: The high-concentration (110mg) peptide powder undergoes moisture sublimation at ultra-low temperatures ($-80^\circ\text{C}$) and near-absolute vacuum conditions, resulting in a uniform, robust, and collapse-free “lyophilized cake” with a snowflake-like crystalline structure. This process not only ensures excellent reconstitution properties—allowing for dissolution within seconds using sterile water for injection or normal saline, resulting in a clear, bubble-free solution—but also stabilizes the molecule at the level of its secondary structure. This significantly mitigates the risks of thermal degradation and conformational loss during international transit and prolonged customs clearance.

🛠️ Technical Specifications & Parameters
Product Specification: 110 mg / Vacuum-Sealed Glass Vial
Molecular Formula: $\text{C}_{211}\text{H}_{342}\text{N}_{54}\text{O}_{68}$
Appearance: White to off-white sterile lyophilized powder / intact solid cake
Validation: Accompanied by the original manufacturer’s HPLC purity chromatogram and MS molecular weight verification report (one certificate per vial; supports digital traceability and batch verification against manufacturer records).

❄️ Storage Requirements & Comprehensive Cold Chain Protection
Laboratory Storage Protocol: Upon receipt, the product must be stored immediately in an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$) while in its unreconstituted state. Maintain conditions that ensure protection from light and moisture, alongside a high-vacuum seal. Storage in standard household appliances or administrative office equipment lacking temperature logging capabilities is strictly prohibited. Given the large 110 mg fill volume and the product’s susceptibility to degradation post-reconstitution, researchers are strongly advised to aliquot the sample into single-experiment doses within a laminar flow hood and freeze them to establish a standardized “Master Stock.” Repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: Strictly adheres to the platform’s “International Shipping and Order Scheduling” policy. 110mg Retatrutide is shipped using high-density, thickened five-layer insulated foam boxes combined with high-capacity, phase-change gel packs via express delivery. This ensures that the peptide molecules maintain their higher-order spatial conformation in a “frozen-locked” state while traversing diverse global climate zones.

📝 Scientific Compliance & Disclaimer (Research Limitations & Compliance)
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Retatrutide 110mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, this product is restricted to academic research within university laboratories, research institutes, or biopharmaceutical R&D centers (e.g., cell receptor binding affinity assays, high-throughput drug screening, long-term metabolic cohort monitoring in large animal models). Any non-compliant use—including human clinical injection, oral administration, substitution for medical prescriptions, or use as an illicit weight-loss agent or performance-enhancing drug/stimulant—is strictly prohibited. This platform enforces rigorous multi-level verification of the “End-Use Statement”; any orders suspected of misuse will be unconditionally cancelled and reported to the relevant compliance authorities.

评价

目前还没有评价

成为第一个“Retatrutide 110mg*10vials” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注